TAUNS Laboratories, Inc.
197A.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | ¥2,368 | ¥1,020 | ¥5,627 | ¥5,561 |
| % Growth | 132.2% | -81.9% | 1.2% | – |
| Cost of Goods Sold | ¥738 | ¥930 | ¥1,663 | ¥1,651 |
| Gross Profit | ¥1,630 | ¥90 | ¥3,964 | ¥3,910 |
| % Margin | 68.8% | 8.8% | 70.5% | 70.3% |
| R&D Expenses | ¥0 | ¥0 | ¥0 | ¥0 |
| G&A Expenses | ¥0 | ¥18 | ¥0 | ¥0 |
| SG&A Expenses | ¥1,082 | ¥1,155 | ¥1,172 | ¥1,117 |
| Sales & Mktg Exp. | ¥0 | ¥688 | ¥0 | ¥0 |
| Other Operating Expenses | ¥0 | ¥0 | ¥0 | ¥0 |
| Operating Expenses | ¥1,082 | ¥1,155 | ¥1,172 | ¥1,117 |
| Operating Income | ¥548 | -¥1,066 | ¥2,792 | ¥2,793 |
| % Margin | 23.1% | -104.5% | 49.6% | 50.2% |
| Other Income/Exp. Net | -¥41 | -¥30 | -¥21 | -¥22 |
| Pre-Tax Income | ¥506 | -¥1,096 | ¥2,771 | ¥2,771 |
| Tax Expense | ¥148 | -¥766 | ¥813 | ¥781 |
| Net Income | ¥358 | -¥330 | ¥1,959 | ¥1,990 |
| % Margin | 15.1% | -32.4% | 34.8% | 35.8% |
| EPS | 3.47 | -3.23 | 19.14 | 19.57 |
| % Growth | 207.4% | -116.9% | -2.2% | – |
| EPS Diluted | 3.33 | -3.05 | 17.94 | 18.55 |
| Weighted Avg Shares Out | 103 | 102 | 102 | 102 |
| Weighted Avg Shares Out Dil | 107 | 108 | 109 | 107 |
| Supplemental Information | – | – | – | – |
| Interest Income | ¥8 | ¥1 | ¥4 | ¥1 |
| Interest Expense | ¥51 | ¥38 | ¥31 | ¥18 |
| Depreciation & Amortization | ¥182 | ¥182 | ¥183 | ¥178 |
| EBITDA | ¥739 | -¥876 | ¥2,986 | ¥2,967 |
| % Margin | 31.2% | -85.8% | 53.1% | 53.4% |